...
首页> 外文期刊>International journal of hematology-oncology and stem cell research. >Nephrotic syndrome as the first manifestation of Acute Myelogenous leukemia
【24h】

Nephrotic syndrome as the first manifestation of Acute Myelogenous leukemia

机译:肾病综合征是急性粒细胞性白血病的首发表现

获取原文
           

摘要

The hematological malignancies associated with nephrotic syndrome are mainly hodgkin’s and non-hodgkin’s lymphomas and chronic lymphocytic leukemia. Acute myelogenous leukemia (AML) has rarely been described in associated with nephritic syndrome. We report a rare case of acute myelogenous leukemia who presented with nephrotic syndrome. A previously healthy 62-year-old man was admitted in nephrology ward because of generalized developing pitting edema during last month. Simultaneously, he had generalized itching and urticaria, polyuria, polydypsia and low grade fever but had no history of weight loss, anorexia and sweating. In laboratory tests he had proteinuria above 3.5 gr/ day. Because of anemia, hematology consultation was done. In peripheral blood, there were myeloblast cells in the circulation at a ratio of 20%. Bone marrow aspiration confirmed a diagnosis of AML M2, showing hypercellular bone marrow with 80-90% leukemic cells, increased M/E ratio, myeloblast (immature cell, fine chromatin, cytoplasmic granule) and these abnormal elements: myeloblast >50% and mature cell about 20%. Unfortunately, we hadn’t renal biopsy as a consequent of patient illness and thrombocytopenia. He received induction chemotherapy, which led to a complete remission and decreasing urinary protein excretion during chemotherapy and no proteinurai at the end of it. Now the patient has received second course of consolidation therapy and remained in complete remission, with no physical and laboratory evidence of proteinuria. It can be concluded that nephrotic syndrome may be additionally associated with AML. In some cases, there is a direct causal effect of the leukemic process on renal function or even pathology, while in others it is exerted indirectly via other complications of the malignancy or the treatment.
机译:与肾病综合征相关的血液系统恶性肿瘤主要是霍奇金淋巴瘤和非霍奇金淋巴瘤以及慢性淋巴细胞性白血病。很少有人将急性髓性白血病(AML)与肾病综合征相关联。我们报告了罕见的急性粒细胞性白血病,并伴有肾病综合征。先前健康的62岁男性由于上个月普遍出现的麻点水肿而被送进肾脏病房。同时,他全身发痒,荨麻疹,多尿,多发性痛和低烧,但没有体重减轻,厌食和出汗的史。在实验室测试中,他的蛋白尿超过3.5克/天。由于贫血,进行了血液学咨询。在外周血中,循环中有成纤维细胞,比例为20%。骨髓穿刺证实诊断为AML M2,表现为具有80-90%白血病细胞,M / E比增加,成纤维细胞(未成熟​​细胞,细染色质,细胞质颗粒)的高细胞骨髓和以下异常因素:成纤维细胞> 50%且成熟细胞约20%。不幸的是,由于患者患病和血小板减少,我们没有进行肾脏活检。他接受了诱导化学疗法,导致化学疗法期间完全缓解并减少了尿蛋白排泄,并且在治疗结束时没有蛋白尿。现在,该患者已接受巩固治疗的第二个疗程,并且完全缓解,没有物理尿和实验室检查证明存在蛋白尿。可以得出结论,肾病综合征可能还与AML相关。在某些情况下,白血病过程对肾功能甚至病理有直接的因果关系,而在另一些情况下,它是通过恶性肿瘤或治疗的其他并发症间接发挥作用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号